NSTM · NovelStem International Corp. · Executive Compensation
$0.01
At close · Oct 7
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.”View the 10-Q filed Aug 14, 2026
Market Cap
$493,324
Shares
49.33M
Volume · Oct 7
11.94K
Avg daily vol (13 sessions)
70.25K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Christine Jenkins | Vice President | Appointed | 2023-01-17 |
| Jan Loeb | President | Appointed | 2023-01-17 |
| Christine Jenkins | Chief Financial Officer | Appointed | 2022-10-04 |
| Jan Loeb | Principal Executive Officer | Appointed | 2022-10-04 |
| Jan Loeb | Executive Chairman | Appointed | 2022-10-04 |
Leadership
- Jan Loeb CEO, Chairman
- Christine Jenkins CFO